Observational Study of Pregnancy and Infant Outcomes Among Women Exposed to Mirikizumab During Pregnancy in US-based Administrative Claims Data (I6T-MC-B003)

03/10/2023
10/12/2024
EU PAS number:
EUPAS105674
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

LY3074828 B003 Protocol Version 1_Redacted (1).pdf

English (1.87 MB - PDF) View document
Study results
Study report
Other information